SG10201809158TA - Device and method for detecting blood group antigens by means of an incomplete antibody - Google Patents
Device and method for detecting blood group antigens by means of an incomplete antibodyInfo
- Publication number
- SG10201809158TA SG10201809158TA SG10201809158TA SG10201809158TA SG10201809158TA SG 10201809158T A SG10201809158T A SG 10201809158TA SG 10201809158T A SG10201809158T A SG 10201809158TA SG 10201809158T A SG10201809158T A SG 10201809158TA SG 10201809158T A SG10201809158T A SG 10201809158TA
- Authority
- SG
- Singapore
- Prior art keywords
- antibody
- cellular
- indicator zone
- directed against
- bound analyte
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
Abstract
Device and method for detecting blood group antigens by means of an incomplete antibody The invention relates to a device for determining a cellular-bound analyte in a liquid sample, comprising a separation matrix with at least one indicator zone. The invention is characterized in that the indicator zone comprises a first antibody directed against the cellular-bound analyte or a fragment thereof and a binding element directed against the first antibody, the first antibody being an incomplete antibody. The separation matrix is preferably designed in the form of the membrane of a lateral flow assay device or as a gel matrix. In a particularly preferable manner, the device comprises a membrane (2) with a charging zone (5) for applying the liquid sample, at least one indicator zone which can interact with the cellular-bound analyte, and at least one absorption region (3) which absorbs the liquid after passing the indicator zone. The indicator zone lies between the charging zone (5) and the absorption region (3). The invention is characterized in that the indicator zone comprises an antibody directed against the cellular-bound analyte or a fragment thereof and a binding element directed against the first antibody, the first antibody being an incomplete antibody. [No Suitable Figure]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102014007851.5A DE102014007851B3 (en) | 2014-05-26 | 2014-05-26 | Apparatus and method for the determination of blood group antigens with an incomplete antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201809158TA true SG10201809158TA (en) | 2018-11-29 |
Family
ID=53276057
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201809158TA SG10201809158TA (en) | 2014-05-26 | 2015-05-23 | Device and method for detecting blood group antigens by means of an incomplete antibody |
SG11201608647TA SG11201608647TA (en) | 2014-05-26 | 2015-05-23 | Device and method for detecting blood group antigens by means of an incomplete antibody |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201608647TA SG11201608647TA (en) | 2014-05-26 | 2015-05-23 | Device and method for detecting blood group antigens by means of an incomplete antibody |
Country Status (14)
Country | Link |
---|---|
US (2) | US11169160B2 (en) |
EP (1) | EP3149477A1 (en) |
JP (1) | JP6683626B2 (en) |
KR (1) | KR102364928B1 (en) |
CN (1) | CN106415273B (en) |
AU (2) | AU2015266394B2 (en) |
CA (1) | CA2945622A1 (en) |
CL (1) | CL2016003038A1 (en) |
DE (1) | DE102014007851B3 (en) |
IL (1) | IL248373B (en) |
MX (1) | MX2016013429A (en) |
RU (1) | RU2726452C2 (en) |
SG (2) | SG10201809158TA (en) |
WO (1) | WO2015180834A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108680756A (en) * | 2018-05-21 | 2018-10-19 | 中国科学院苏州生物医学工程技术研究所 | A kind of incomplete antibody detection kit and detection method |
CN114137231B (en) * | 2022-01-29 | 2022-04-29 | 北京大有天弘科技有限公司 | Detection kit for blood group irregular antibody and application thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3445816C1 (en) * | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flat diagnostic agent |
JPS61271455A (en) | 1985-05-28 | 1986-12-01 | Olympus Optical Co Ltd | Immunological analysis |
DE3686474T2 (en) * | 1985-10-11 | 1993-02-11 | Abbott Lab | DIAGNOSTIC SAMPLE. |
US4816413A (en) | 1986-09-08 | 1989-03-28 | Immucor, Inc. | Solid phase indicator red blood cells and method |
AU8328287A (en) | 1986-11-13 | 1988-06-01 | Genelabs Incorporated | Blood affinity diagnostic method |
US4943522A (en) * | 1987-06-01 | 1990-07-24 | Quidel | Lateral flow, non-bibulous membrane assay protocols |
US5338689A (en) * | 1987-08-24 | 1994-08-16 | Stiftung Fur Diagnostische Forschung | Method and card for detecting antigens and/or antibodies |
US5780248A (en) * | 1993-07-15 | 1998-07-14 | Ortho Diagnostic Systems, Inc. | Foil sealed cassette for agglutination reactions and liner therefor |
JP2001133457A (en) | 1999-11-05 | 2001-05-18 | Dainabot Co Ltd | Immunoanalysis device with improved stability, and method for improving its stability |
US7087203B2 (en) * | 2000-11-17 | 2006-08-08 | Nagaoka & Co., Ltd. | Methods and apparatus for blood typing with optical bio-disc |
WO2003023354A2 (en) | 2001-09-07 | 2003-03-20 | Burstein Technologies, Inc. | Optical bio-disc systems for nuclear morphology based identification |
CN1186636C (en) | 2002-12-31 | 2005-01-26 | 江西中德生物工程有限公司 | Method for detecting ABO blood type using immuno-chromatography, its prepared indicator paper and use |
EP1642139A1 (en) | 2003-07-08 | 2006-04-05 | Inverness Medical Switzerland GmbH | Particle agglutination detection method and device |
DE10330981B4 (en) * | 2003-07-09 | 2010-04-01 | Medion Diagnostics Ag | Apparatus and method for simultaneously performing blood grouping, serum cross-checking and antibody-screening |
DE10330982A1 (en) | 2003-07-09 | 2005-02-17 | Prisma Diagnostika Gmbh | Apparatus and method for the simultaneous determination of blood group antigens |
CN103091487A (en) | 2005-11-12 | 2013-05-08 | 平台诊断有限公司 | Agglutination assay |
DE102006062619B4 (en) | 2006-12-29 | 2012-04-26 | Medion Diagnostics Ag | Method for the determination of minor cell populations in heterogeneous cell populations |
JP4806645B2 (en) | 2007-03-23 | 2011-11-02 | ベックマン コールター, インコーポレイテッド | Carrier for immunological examination and examination method using the carrier |
CN201053966Y (en) | 2007-05-21 | 2008-04-30 | 四川省迈克科技有限责任公司 | Quick detection reagent kit for blood type and transfusion matching type |
CN101603967B (en) | 2008-06-10 | 2015-02-18 | 英科新创(厦门)科技有限公司 | Method for fast testing human ABO/Rh/MN blood type and kit |
CN101957370A (en) | 2009-07-15 | 2011-01-26 | 英科新创(厦门)科技有限公司 | Method and detection strip for rapidly detecting human blood group antibodies |
-
2014
- 2014-05-26 DE DE102014007851.5A patent/DE102014007851B3/en active Active
-
2015
- 2015-05-23 CA CA2945622A patent/CA2945622A1/en active Pending
- 2015-05-23 EP EP15725997.9A patent/EP3149477A1/en active Pending
- 2015-05-23 US US15/312,365 patent/US11169160B2/en active Active
- 2015-05-23 SG SG10201809158TA patent/SG10201809158TA/en unknown
- 2015-05-23 MX MX2016013429A patent/MX2016013429A/en unknown
- 2015-05-23 RU RU2016142888A patent/RU2726452C2/en active
- 2015-05-23 WO PCT/EP2015/001067 patent/WO2015180834A1/en active Application Filing
- 2015-05-23 SG SG11201608647TA patent/SG11201608647TA/en unknown
- 2015-05-23 KR KR1020167031928A patent/KR102364928B1/en active IP Right Grant
- 2015-05-23 AU AU2015266394A patent/AU2015266394B2/en active Active
- 2015-05-23 JP JP2016564216A patent/JP6683626B2/en active Active
- 2015-05-23 CN CN201580027408.0A patent/CN106415273B/en active Active
-
2016
- 2016-10-16 IL IL248373A patent/IL248373B/en active IP Right Grant
- 2016-11-25 CL CL2016003038A patent/CL2016003038A1/en unknown
-
2020
- 2020-05-25 AU AU2020203425A patent/AU2020203425B2/en active Active
-
2021
- 2021-09-22 US US17/448,506 patent/US20220003789A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11169160B2 (en) | 2021-11-09 |
SG11201608647TA (en) | 2016-11-29 |
IL248373A0 (en) | 2016-11-30 |
WO2015180834A1 (en) | 2015-12-03 |
US20220003789A1 (en) | 2022-01-06 |
IL248373B (en) | 2020-05-31 |
AU2015266394B2 (en) | 2020-06-04 |
DE102014007851B3 (en) | 2015-11-12 |
RU2726452C2 (en) | 2020-07-14 |
CL2016003038A1 (en) | 2017-10-13 |
EP3149477A1 (en) | 2017-04-05 |
NZ725664A (en) | 2021-10-29 |
AU2015266394A1 (en) | 2016-11-17 |
CN106415273A (en) | 2017-02-15 |
RU2016142888A3 (en) | 2018-11-01 |
CA2945622A1 (en) | 2015-12-03 |
JP2017519972A (en) | 2017-07-20 |
KR102364928B1 (en) | 2022-02-17 |
MX2016013429A (en) | 2017-05-04 |
CN106415273B (en) | 2019-04-19 |
RU2016142888A (en) | 2018-06-26 |
US20170122968A1 (en) | 2017-05-04 |
JP6683626B2 (en) | 2020-04-22 |
KR20170005008A (en) | 2017-01-11 |
AU2020203425A1 (en) | 2020-06-11 |
AU2020203425B2 (en) | 2022-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020009021A (en) | Assays for detecting the presence or amount of an anti-drug antibody. | |
AU2018200278B2 (en) | Antibodies to aripiprazole and use thereof | |
MX2018009242A (en) | Methods and apparatus for detecting compounds in liquids. | |
WO2014015194A3 (en) | Methods for detecting and measuring aggregation | |
BR112014032304A2 (en) | sandwich method, system and assay for the quantitative or qualitative determination of a target component in a liquid sample, kit for preparing a liquid sample, and microfluidic device. | |
MX364886B (en) | Ophthalmic lens with a microfluidic system. | |
WO2012177940A3 (en) | Microfluidic devices and methods for separating and detecting constituents in a fluid sample | |
EP3933406A3 (en) | Antibodies to risperidone and use thereof | |
MX2009013388A (en) | Multiple analysis of blood samples. | |
WO2013134741A3 (en) | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results | |
WO2014031668A3 (en) | Antibodies to quetiapine and use thereof | |
WO2014031662A3 (en) | Antibodies to olanzapine and use thereof | |
EP3508852A4 (en) | Analyte concentration measuring method, particle containing agglutinated fluorescent material, and inspection device | |
WO2015131169A3 (en) | Personalized myeloma detection | |
GB2528657A8 (en) | Sample analysing device | |
IN2015DN04062A (en) | ||
WO2015114316A3 (en) | Fluidic device comprising immobilised reagents within a chamber | |
EP3460478A4 (en) | Blood sample analysis method and system, for determining diabetes | |
GB201113992D0 (en) | Device | |
EP4300101A3 (en) | Antigenic peptides and uses thereof for diagnosing and treating autism | |
WO2014140570A3 (en) | Eluate analysis and collection | |
MY183701A (en) | Immunochromatographic test piece and immunochromatography method using same | |
MX2015004419A (en) | Detecting an analyte and determining the concentration of an analyte using magnetizable beads. | |
MX2019000592A (en) | Liquid analytical reagent dispensing apparatus and analytical kits and methods of use related thereto. | |
SG10201809158TA (en) | Device and method for detecting blood group antigens by means of an incomplete antibody |